A mutation in the transforming growth factor β type II receptor gene promoter associated with loss of gene expression

Cancer Research

Volumn 56, Issue 21, 1996, Pages 4831-4835

  Muñoz Antonia, Teresita ^a   Li, Xiaochuan ^a   Reiss, Michael ^b   Jackson, Rosalind ^a   Antonia, Scott ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CANCER CELL CULTURE; DNA SEQUENCE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; TUMOR GROWTH; VULVA CARCINOMA;

CELL LINE; GENE EXPRESSION; HUMANS; MUTATION; PROMOTER REGIONS (GENETICS); RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER;

EID: 0029902905     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Roberts, A. B., and Sporn, M. B. Transforming growth factor β. Adv. Cancer Res., 51: 107-145, 1988.
2. Moses, H. L., Yang, E. Y., and Pietenpol, J. A. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell, 60: 245-247, 1990.
3. 1/S-phase growth arrest Mol. Cell. Biol., 11: 1185-1194, 1991.
4. Polyak, K., Kato, J. Y., Solomon, M. J., Sheer, C. J., Massaque, J., Roberts, J. M., and Koff, A. p27 kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
5. Wrana, J. L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X-F., and Massaque, J. TGF-β signals through heteromeric protein kinase receptor complex. Cell, 71: 1003-1014, 1992
6. Wrana, J., Attisano, L., Weiser, R., Ventura, F., and Massaque, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370: 341-347, 1994.
7. Yamashita, H., ten Dijke, P., Franzen, P., Miyazono, K., and Heldin, C-H. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor β. J Biol Chem., 269: 20172-20178, 1994.
8. Fynan, T. M., and Reiss, M. Resistance to inhibition of cell growth by transforming growth factor β and its role in oncogenesis. Crit. Rev. Oncog., 4: 493-540, 1993.
9. Inagaki, M., Moustakas, A., Lin, H. Y., Lodish, H. F., and Carr, B. I. Growth inhibition by transforming growth factor β (TGF-β) type II is restored in TGF-β-resistant hepatoma cell lines after expression of TGF-β receptor type II cDNA. Proc. Natl. Acad. Sci. USA, 90: 5359-5363, 1993.
10. Game, S. M., Huelsen, A., Patel, V., Donnelly, M., Yeudall, W. A., Stone, A., Fusenig, N. E., and Prime, S. S. Progressive abrogation of TGF-β1 and EGF growth control is associated with tumor progression in ras-transfected human keratinocytes. Int. J. Cancer, 52: 461-470, 1992.
11. Serrera, G., Zhou, J., Mills, D., and LePak, N. Decreased transforming growth factor-β response and binding m insulin-independent teratoma-derived cell lines with increased tumorigenic properties. J Cell. Physiol., 149: 503-511, 1991
12. Geiser, A. G., Burmester, J. K., Webbink, R., Roberts, A. B., and Sporn, M. B. Inhibition of growth by transforming growth factor-β following fusion of two nonresponsive human carcinoma cell lines. J. Biol. Chem., 267: 2588-2593, 1992.
13. Sun, L., Wu, G., Willson, J. K. V., Zborowski, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L. E., Wang, X-L., and Brattain, M. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human MCF-7 cells. J. Biol. Chem., 269: 26449-26455, 1994.
14. Park, K., Kim, S-J., Bang, Y-J., Park, J-G., Kim, N. K., Roberts, A., and Sporn, M. B. Genetic changes in transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA, 91: 8772-8776, 1994
15. Ji, H., Stout, L. E., Zhang, Q., Zhang, R., Leung, H. T., and Leung, B. S. Absence of transforming growth factor-β responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1. J. Cell. Biochem., 54: 332-342, 1994.
16. Guo, Y. P., Jacobs, S. C., and Kypriano, N. Decreased expression of TGF-β1 type I and type II receptors m human prostate cancer. Proc. Am. Assoc. Cancer Res., 37: 245, 1996.
17. Lee, H. Y., Kim, D. H., Chang, J. H., Roberts, A. B., and Kim, S. J. Human transforming growth factor β type I and type II receptor gene mutation in human osteosarcoma. Proc Am. Assoc. Cancer Res., 37: 37, 1996
18. Norgaard, P., Damstrup, L., Rygaard, K., Spang-Thomsen, M., and Skovgaarrd Poulsen, H. Growth suppression by transforming growth factor β of human small-cell lung cancer lines is associated with expression of the type II receptor. Br. J. Cancer, 69: 802-808, 1994.
19. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutteraugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995
20. Wang, Y. Q., Sizeland, X. F., Wang, X. F., and Sassoon, D. Restricted expression of type-II TGF-β receptor in murine embryonic development suggests a central role in tissue modeling and CNS patterning. Mech Dev., 52: 275-289, 1995.
21. Humphries, D. E., Bloom, B. B., Fine, A., and Goldstein, R. H. Structure and expression of the promoter for the human type II transforming growth factor-β receptor. Biochem Biophys. Res. Commun., 203: 1020-1027, 1994.
22. Bae, H. W., Geiser, A. G., Kim, D. H., Chung, M. T., Burmester, J. K., Sporn, M. B., Roberts, A. B., and Kim, S-J. Characterization of the promoter region of the human transforming growth factor-β type II receptor gene. J Biol. Chem., 270: 29460-29468, 1995.
23. Kadonga, J. T., Jones, K. A., and Tijan, R. Promoter-specific activation of RNA polymerase II transcription by Sp1. Trends Biochem Sci., 11: 20-23, 1986
24. Garrigue-Antar, L., Muñoz-Antonia, T., Antonia, S. J., Gesmonde, J., Vellucci, V. F., and Reiss, M. Missense mutations of the transforming growth factor-β type II receptor in human head and neck and cancer squamous carcinoma cells. Cancer Res., 55: 3982-3987, 1995.
25. Fabricant, R. N., DeLarco, J. E., and Todaro, G. J. Nerve growth factor receptors on human melanoma cells in culture. Proc. Natl. Acad. Sci. USA, 74: 565-569, 1977
26. Reiss, M., Muñoz-Antonia, T., Cowan, J. M., Wilkins, P. C., Zhou, Z. L., and Vellucci, V. Resistance of human squamous carcinomas cells to transforming growth factor β1 is a recessive trait. Proc. Natl Acad. Sci. USA, 90: 6280-6284, 1993
27. Pirisi, L., Creek, K. E., Doniger, J., and DiPaolo, J. A. Continuous growth of cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA. Carcinogenesis (Lond), 9: 1573-1579, 1988.
28. Lacy, J., Summers, W. P., and Summers, W. C. Post-transcriptional mechanisms of deregulation of MYC following conversion of a human B-cell line by Epstein-Barr virus EMBO J., 8: 1973-1980, 1989.
29. Patwardhan, S., Gashler, A., Siegel, M. G., Chang, L. C., Joseph, L. J., Shows, T. B., El Beau, M. M., and Sukhatme, V. P. EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors. Oncogene, 6: 917-928, 1991.
30. Choo, K. H., Filby, R. G., Jemmings, I. G., Peterson, G., and Fowler, K. Vectors for expression and amplification of cDNA in mammalian cells: expression of rat phenylalanine hydroxylase. DNA (NY), 5: 529-537, 1986.
31. Lin, H. L., Wang, X. F., Ng-Eaton, E., Weinberg, R. A., and Lodish, H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68: 775-785, 1992.
32. Katz, L., Kingsbury, D., and Helsinki, D. Stimulation by cyclin adenosine monophosphate of plasmid deoxynbonucleic acid replication and catabolic repression of the plasmid deoxyribonucleic acid-protein complex J. Bacteriol., 114: 577-591, 1973
33. Cowell, J. K., Bia, B., and Akoulitchev, A. A novel mutation in the promoter region in a family with a mild form of retinoblastoma indicates the location of a new regulatory domain for the RB1 gene. Oncogene, 12: 431-436, 1996.
34. Yang, W-S., Nevin, D. N., Peng, R., Brunzell, J. D., and Deeb, S. S. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipedemia and low LPL activity Proc. Natl. Acad. Sci USA, 92: 4462-4466, 1995.
35. Angotti, E., Mele, E., Costanzo, F., and Avvedimento, E. V. A polymorphism (G-A transition) in the -78 position of the apolipoprotein A-1 promoter increases transcription efficiency J. Biol. Chem., 269: 17371-17374, 1994.